Group 1 - The core point of the announcement is the preliminary pricing for the share transfer of Jilin Xidian Pharmaceutical Technology Development Co., Ltd., set at 24.69 yuan per share [3][4] - The share transfer will not be conducted through centralized bidding or block trading, and the shares acquired cannot be transferred within six months [3][4] - A total of 15 valid bids were received from institutional investors, with a total subscription of 3,720,000 shares, resulting in a subscription multiple of 4.86 times [4] Group 2 - The transfer is expected to involve five institutional investors, with a total of 765,000 shares to be transferred [4] - The announcement confirms that the share transfer does not involve any change in company control and will not affect the governance structure or ongoing operations of the company [6]
吉林省西点药业科技发展股份有限公司股东询价转让定价情况提示性公告